HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M V Catania Selected Research

M V Catania Research Topics

Disease

3Fragile X Syndrome (Martin Bell Syndrome)
01/2021 - 09/2004
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2001 - 01/2001
1Brain Diseases (Brain Disorder)
05/2024
1Autistic Disorder (Autism)
01/2021
1Intellectual Disability (Idiocy)
01/2021
1Gliosis
07/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2017
1Drug Resistant Epilepsy
09/2006
1Seizures (Absence Seizure)
08/2006
1Hyperkinesis
09/2004
1Cognitive Dysfunction
09/2004
1Hyperalgesia
05/2002
1Pain (Aches)
05/2002
1Acute Pain
05/2002
1Peripheral Nerve Injuries
05/2002
1Chronic Pain
05/2002

Drug/Important Bio-Agent (IBA)

2Fragile X Mental Retardation ProteinIBA
01/2021 - 05/2015
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021 - 05/2015
1messenger ribonucleoproteinIBA
05/2024
1Proteins (Proteins, Gene)FDA Link
01/2021
1Peptides (Polypeptides)IBA
07/2017
1Endothelin-1 (Endothelin 1)IBA
07/2017
1Messenger RNA (mRNA)IBA
05/2015
1Glial Fibrillary Acidic ProteinIBA
09/2006
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2006
14-Aminopyridine (4 Aminopyridine)FDA Link
08/2006
1Dopamine (Intropin)FDA LinkGeneric
09/2004
1Acetylcarnitine (Alcar)IBA
05/2002
1LY 341495IBA
05/2002
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
06/2001
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2001
1Glutamate Receptors (Glutamate Receptor)IBA
01/2001

Therapy/Procedure

1Analgesia
05/2002